SIGNIFICANCE OF ALCOHOL-INDUCED HYPERTRIGLYCERIDEMIA IN PATIENTS WITH TYPE-IV HYPERLIPOPROTEINEMIA

被引:6
|
作者
MENDELSON, JH
MELLO, NK
机构
[1] HARVARD UNIV, ALCOHOL & DRUG ABUSE RES CTR, MED SCH, DEPT PSYCHIAT, BOSTON, MA 02138 USA
[2] MCLEAN HOSP, ABUSE RES CTR, BOSTON, MA 02100 USA
[3] NIAAA, LAB ALCOHOL RES, ROCKVILLE, MD 20800 USA
关键词
D O I
10.7326/0003-4819-80-2-270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:270 / 271
页数:2
相关论文
共 50 条
  • [41] THE LIVER AND PRIMARY TYPE-IV HYPERLIPOPROTEINEMIA - A PATHOLOGICAL-STUDY
    GARIOT, P
    SEUROT, JM
    POINTEL, JP
    CONTETAUDONNEAU, JL
    GAY, G
    DROUIN, P
    DEBRY, G
    HUMAN NUTRITION-CLINICAL NUTRITION, 1982, 36 (05): : 351 - 361
  • [42] DECREASED NITROBLUE TETRAZOLIUM REDUCTION OF GRANULOCYTES IN TYPE-IV HYPERLIPOPROTEINEMIA
    JARSTRAND, C
    ANGELIN, B
    EINARSSON, K
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1979, 94 (06): : 897 - 901
  • [43] MULTIPLE INTRAOSSEOUS LIPOMAS WITH TYPE-IV HYPERLIPOPROTEINEMIA - CASE REPORT
    FREIBERG, RA
    AIR, GW
    GLUECK, CJ
    ISHIKAWA, T
    ABRAMS, NR
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1974, A 56 (08): : 1729 - 1732
  • [44] LIPID REDUCING ACTION OF PHENFORMIN IN PRIMARY TYPE-IV HYPERLIPOPROTEINEMIA
    LANG, PD
    VOLLMAR, J
    KLEMENS, UH
    LOWIS, PV
    GRIES, FA
    KOSCHINSKY, T
    HUTH, K
    PILZ, E
    SCHLIERF, G
    KREMER, GJ
    LENHART, P
    SCHWANDT, P
    HAMMERL, H
    STUDLAR, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1973, 98 (48) : 2280 - 2286
  • [45] THE CONCENTRATION OF HIGH-DENSITY LIPOPROTEIN IN PATIENTS WITH TYPE-IV HYPERLIPOPROTEINEMIA AND THE EFFECT OF CLOFIBRATE
    BROOK, JG
    LAVY, A
    AVIRAM, M
    ZINDER, O
    ATHEROSCLEROSIS, 1980, 36 (04) : 461 - 469
  • [46] TREATMENT OF HYPERLIPOPROTEINEMIA, TYPE-II AND TYPE-IV WITH PIRIFIBRATE - 100 OBSERVATIONS
    BONORA, V
    CALALABUIG, JR
    CAVIOLA, E
    SOLER, J
    PUEYO, JM
    MICALO, T
    CANO, RP
    CLINICAL THERAPEUTICS, 1981, 4 (03) : 192 - 200
  • [47] COENZYME-A IN THE TREATMENT OF FAMILIAL AND NONFAMILIAL TYPE-IV HYPERTRIGLYCERIDEMIA
    BAROZZI, G
    GADDI, A
    DIGIULIO, R
    MARSIGLI, L
    LAREGINA, G
    SANGIORGI, Z
    FRATICELLI, G
    DESCOVICH, GC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (05): : 925 - 932
  • [48] LONG-ACTING FENFLURAMINE (PONDERAL PACAPS) IN TYPE-IV HYPERLIPOPROTEINEMIA
    BIELMANN, PP
    BRUN, LD
    LUPIEN, PJ
    MOORJANI, S
    GAGNE, C
    NADEAU, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (07): : 559 - 559
  • [49] THE EFFECT OF WEIGHT-REDUCTION ON BILIARY LIPID-METABOLISM IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE-IV
    LEIJD, B
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (12): : 1185 - 1189
  • [50] TYPE-IV HYPERLIPOPROTEINEMIA AND ITS RELATION TO ARTERIOSCLEROTIC RISK-FACTORS
    VAUGHTERS, R
    JOURNAL OF THE SOUTH CAROLINA MEDICAL ASSOCIATION, 1978, 74 (08): : 370 - 371